Immediate Impact
16 by Nobel laureates 22 from Science/Nature 59 standout
Citing Papers
Trends in peptide drug discovery
2021 Standout
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
2021 Standout
Works of Maïthé Corbani being referenced
Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile
2016
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maïthé Corbani | 303 | 213 | 378 | 30 | 851 | |
| Ryoichi Teruyama | 288 | 291 | 423 | 37 | 1.0k | |
| R. W. Swann | 154 | 289 | 616 | 21 | 1.0k | |
| Shi‐fang Lu | 205 | 170 | 299 | 25 | 953 | |
| M Alexandrová | 154 | 102 | 566 | 40 | 993 | |
| Cristina Cocco | 205 | 208 | 265 | 44 | 961 | |
| Lei Wang | 259 | 121 | 379 | 42 | 1.1k | |
| A. Ermisch | 212 | 273 | 342 | 44 | 877 | |
| Yoshihiro Tokugawa | 218 | 154 | 230 | 30 | 898 | |
| Makoto Kawasaki | 294 | 227 | 375 | 73 | 1.1k | |
| J Roffi | 227 | 91 | 277 | 52 | 959 |
All Works
Login with ORCID to disown or claim papers
Loading papers...